AUSTIN, Texas (AP) _ Mirna Therapeutics Inc. (SYBX) on Monday reported a loss of $11.9 million in its third quarter.
On a per-share basis, the Austin, Texas-based company said it had a loss of $1.66.
The biopharmaceutical company posted revenue of $111,000 in the period.
Mirna Therapeutics shares have declined 21 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $10, a climb of 14 percent in the last 12 months.